Detail
Článek
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Antioxidant, Anti-Inflammatory, and Multidrug Resistance Modulation Activity of Silychristin Derivatives

J. Viktorová, S. Dobiasová, K. Řehořová, D. Biedermann, K. Káňová, K. Šeborová, R. Václavíková, K. Valentová, T. Ruml, V. Křen, T. Macek,

. 2019 ; 8 (8) : . [pub] 20190814

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc19035802

Grantová podpora
INTER-COST LTC19007 and LTC19020 Ministerstvo Školství, Mládeže a Tělovýchovy
18-00150S Grantová agentura České Republiky
CZ.2.16/3.1.00/21537 and CZ.2.16/3.1.00/24503 Operational Program Prague-Competitiveness
NPU I (LO) (MSMT-43760/2015) Czech National Program of Sustainability

Silychristin A is the second most abundant compound of silymarin. Silymarin complex was previously described as an antioxidant with multidrug resistance modulation activity. Here, the results of a classical biochemical antioxidant assay (ORAC) were compared with a cellular assay evaluating the antioxidant capacity of pure silychristin A and its derivatives (anhydrosilychristin, isosilychristin and 2,3-dehydrosilychristin A). All the tested compounds acted as antioxidants within the cells, but 2,3-dehydro- and anhydro derivatives were almost twice as potent as the other tested compounds. Similar results were obtained in LPS-stimulated macrophages, where 2,3-dehydro- and anhydrosilychristin inhibited NO production nearly twice as efficiently as silychristin A. The inhibition of P-glycoprotein (P-gp) was determined in vitro, and the respective sensitization of doxorubicin-resistant ovarian carcinoma overproducing P-gp was detected. Despite the fact that the inhibition of P-gp was demonstrated in a concentration-dependent manner for each tested compound, the sensitization of the resistant cell line was observed predominantly for silychristin A and 2,3-dehydrosilychristin A. However, anhydrosilychristin and isosilychristin affected the expression of both the P-gp (ABCB1) and ABCG2 genes. This is the first report showing that silychristin A and its 2,3-dehydro-derivative modulate multidrug resistance by the direct inhibition of P-gp, in contrast to anhydrosilychristin and isosilychristin modulating multidrug resistance by downregulating the expression of the dominant transmembrane efflux pumps.

000      
00000naa a2200000 a 4500
001      
bmc19035802
003      
CZ-PrNML
005      
20191010110719.0
007      
ta
008      
191007s2019 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/antiox8080303 $2 doi
035    __
$a (PubMed)31416138
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Viktorová, Jitka $u Department of Biochemistry and Microbiology, University of Chemistry and Technology Prague, Technická 5, CZ 166 28 Prague, Czech Republic. prokesoj@vscht.cz.
245    10
$a Antioxidant, Anti-Inflammatory, and Multidrug Resistance Modulation Activity of Silychristin Derivatives / $c J. Viktorová, S. Dobiasová, K. Řehořová, D. Biedermann, K. Káňová, K. Šeborová, R. Václavíková, K. Valentová, T. Ruml, V. Křen, T. Macek,
520    9_
$a Silychristin A is the second most abundant compound of silymarin. Silymarin complex was previously described as an antioxidant with multidrug resistance modulation activity. Here, the results of a classical biochemical antioxidant assay (ORAC) were compared with a cellular assay evaluating the antioxidant capacity of pure silychristin A and its derivatives (anhydrosilychristin, isosilychristin and 2,3-dehydrosilychristin A). All the tested compounds acted as antioxidants within the cells, but 2,3-dehydro- and anhydro derivatives were almost twice as potent as the other tested compounds. Similar results were obtained in LPS-stimulated macrophages, where 2,3-dehydro- and anhydrosilychristin inhibited NO production nearly twice as efficiently as silychristin A. The inhibition of P-glycoprotein (P-gp) was determined in vitro, and the respective sensitization of doxorubicin-resistant ovarian carcinoma overproducing P-gp was detected. Despite the fact that the inhibition of P-gp was demonstrated in a concentration-dependent manner for each tested compound, the sensitization of the resistant cell line was observed predominantly for silychristin A and 2,3-dehydrosilychristin A. However, anhydrosilychristin and isosilychristin affected the expression of both the P-gp (ABCB1) and ABCG2 genes. This is the first report showing that silychristin A and its 2,3-dehydro-derivative modulate multidrug resistance by the direct inhibition of P-gp, in contrast to anhydrosilychristin and isosilychristin modulating multidrug resistance by downregulating the expression of the dominant transmembrane efflux pumps.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Dobiasová, Simona $u Department of Biochemistry and Microbiology, University of Chemistry and Technology Prague, Technická 5, CZ 166 28 Prague, Czech Republic.
700    1_
$a Řehořová, Kateřina $u Department of Biochemistry and Microbiology, University of Chemistry and Technology Prague, Technická 5, CZ 166 28 Prague, Czech Republic.
700    1_
$a Biedermann, David $u Laboratory of Biotransformation, Institute of Microbiology, Czech Academy of Sciences, Vídeňská 1083, CZ 142 20 Prague, Czech Republic.
700    1_
$a Káňová, Kristýna $u Laboratory of Biotransformation, Institute of Microbiology, Czech Academy of Sciences, Vídeňská 1083, CZ 142 20 Prague, Czech Republic.
700    1_
$a Šeborová, Karolína $u Toxicogenomics Unit, National Institute of Public Health, Šrobárova 49, CZ 100 00 Prague, Czech Republic. Laboratory of Pharmacogenomics, Biomedical Center, Faculty of Medicine in Pilsen, Charles University, alej Svobody 1655, CZ 323 00 Pilsen, Czech Republic.
700    1_
$a Václavíková, Radka $u Toxicogenomics Unit, National Institute of Public Health, Šrobárova 49, CZ 100 00 Prague, Czech Republic. Laboratory of Pharmacogenomics, Biomedical Center, Faculty of Medicine in Pilsen, Charles University, alej Svobody 1655, CZ 323 00 Pilsen, Czech Republic.
700    1_
$a Valentová, Kateřina $u Laboratory of Biotransformation, Institute of Microbiology, Czech Academy of Sciences, Vídeňská 1083, CZ 142 20 Prague, Czech Republic.
700    1_
$a Ruml, Tomáš $u Department of Biochemistry and Microbiology, University of Chemistry and Technology Prague, Technická 5, CZ 166 28 Prague, Czech Republic.
700    1_
$a Křen, Vladimír $u Laboratory of Biotransformation, Institute of Microbiology, Czech Academy of Sciences, Vídeňská 1083, CZ 142 20 Prague, Czech Republic.
700    1_
$a Macek, Tomáš $u Department of Biochemistry and Microbiology, University of Chemistry and Technology Prague, Technická 5, CZ 166 28 Prague, Czech Republic.
773    0_
$w MED00200130 $t Antioxidants (Basel, Switzerland) $x 2076-3921 $g Roč. 8, č. 8 (2019)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31416138 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20191007 $b ABA008
991    __
$a 20191010111138 $b ABA008
999    __
$a ind $b bmc $g 1452462 $s 1074352
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 8 $c 8 $e 20190814 $i 2076-3921 $m Antioxidants $n Antioxidants $x MED00200130
GRA    __
$a INTER-COST LTC19007 and LTC19020 $p Ministerstvo Školství, Mládeže a Tělovýchovy
GRA    __
$a 18-00150S $p Grantová agentura České Republiky
GRA    __
$a CZ.2.16/3.1.00/21537 and CZ.2.16/3.1.00/24503 $p Operational Program Prague-Competitiveness
GRA    __
$a NPU I (LO) (MSMT-43760/2015) $p Czech National Program of Sustainability
LZP    __
$a Pubmed-20191007

Najít záznam

Citační ukazatele

Nahrávání dat...

Možnosti archivace

Nahrávání dat...